New Drug Modalities – Asrar Qureshi’s Blog Post 1047
New Drug Modalities – Asrar Qureshi’s Blog Post 1047 Dear Colleagues! This is Asrar Qureshi’s Blog Post 1047 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com for publishing our contributions here. Credit: Edward Jenner Credit: Ivan Samkov Credit: Jonathan Borba This post is based on Boston Consulting Group article authored by Lu Chen, Brian Bush, Mike Brochu, and Gian King. Link at the end. Preamble The second annual report from BCG reviews the growth of new drug modalities. The report tracks the progress in each of the six categories of novel modalities in terms of number of products and pipeline revenue. It will help to see which modalities are progressing more rapidly and its implication for patients and biopharma companies and investors. For us in Pakistan, most of this may sound completely foreign, but we are already using many of these products. New Modalities L...